Altered expression of miR-29a-3p and miR-34a-5p by specific inhibition of GSK3β in the MPP

7-BIO GSK3β inhibitor MPP+ Neuroprotection Parkinson's disease SH-SY5Y miR-29a miR-29a-3p miR-34a miR-34a-5p

Journal

Non-coding RNA research
ISSN: 2468-0540
Titre abrégé: Noncoding RNA Res
Pays: Netherlands
ID NLM: 101688191

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 19 07 2021
revised: 15 12 2021
accepted: 29 12 2021
entrez: 28 1 2022
pubmed: 29 1 2022
medline: 29 1 2022
Statut: epublish

Résumé

In the current study, the effects of 7-BIO as a specific GSK3β inhibitor was examined on cell survival and expression of miR-29a-3p and miR-34a-5p in neurotoxin MPP

Identifiants

pubmed: 35087989
doi: 10.1016/j.ncrna.2021.12.004
pii: S2468-0540(21)00054-8
pmc: PMC8777260
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1-6

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

There is no conflict of interest between the authors.

Références

Mol Genet Genomic Med. 2018 Nov;6(6):975-981
pubmed: 30221494
Front Mol Neurosci. 2017 Nov 28;10:393
pubmed: 29234273
J Biotechnol. 2011 Mar 20;152(3):96-101
pubmed: 21295623
PLoS One. 2018 Aug 23;13(8):e0197946
pubmed: 30138351
Proc Natl Acad Sci U S A. 1985 Apr;82(7):2173-7
pubmed: 3872460
Neuroscience. 2012 Jun 1;211:51-76
pubmed: 22108613
J Neurochem. 1988 Jun;50(6):1900-7
pubmed: 3259619
Neurology. 2007 Jan 30;68(5):384-6
pubmed: 17082464
Springerplus. 2015 Jun 12;4(Suppl 1):L49
pubmed: 27386211
Chem Biol. 2003 Dec;10(12):1255-66
pubmed: 14700633
Ann Neurol. 2015 May;77(5):895-901
pubmed: 25675938
J Mol Neurosci. 2020 May;70(5):769-777
pubmed: 32043204
J Mol Cell Biol. 2011 Feb;3(1):44-50
pubmed: 21278451
Science. 1983 Feb 25;219(4587):979-80
pubmed: 6823561
Front Cell Neurosci. 2015 May 28;9:209
pubmed: 26074776
Life Sci. 1985 Jul 1;36(26):2503-8
pubmed: 2861548
Cell Stem Cell. 2021 Feb 4;28(2):343-355.e5
pubmed: 33545081
J Biol Chem. 2007 Jun 1;282(22):16502-10
pubmed: 17403689
J Neurosci Res. 2014 Aug;92(8):1071-7
pubmed: 24648008
BMC Mol Biol. 2012 Jan 31;13:4
pubmed: 22292433
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12747-52
pubmed: 14557550
Gene. 2018 Jul 1;662:54-65
pubmed: 29631008
Neurodegener Dis. 2006;3(1-2):5-11
pubmed: 16909030
Dev Cell. 2009 Jul;17(1):9-26
pubmed: 19619488
Exp Brain Res. 2017 Aug;235(8):2359-2374
pubmed: 28526930
FEBS Lett. 1985 Jul 8;186(2):224-8
pubmed: 3874094
NeuroRx. 2005 Jul;2(3):484-94
pubmed: 16389312
J Mol Neurosci. 2015 Dec;57(4):561-70
pubmed: 26346600
Stem Cells. 2012 May;30(5):865-75
pubmed: 22290867
Front Mol Neurosci. 2020 Jun 03;13:81
pubmed: 32581704
Expert Opin Ther Pat. 2015 May;25(5):583-93
pubmed: 25887337
Cell. 1993 Dec 3;75(5):843-54
pubmed: 8252621
Sci Rep. 2017 Jul 14;7(1):5411
pubmed: 28710399
Cell Mol Neurobiol. 2017 May;37(4):655-664
pubmed: 27412761
Parkinsonism Relat Disord. 2008;14 Suppl 2:S116-8
pubmed: 18583172
Oxid Med Cell Longev. 2017;2017:5189138
pubmed: 28811864
Hum Mol Genet. 2013 Feb 1;22(3):608-20
pubmed: 23125283
J Cell Sci. 2004 Nov 15;117(Pt 24):5731-7
pubmed: 15522889

Auteurs

Morteza Ahmadzadeh-Darinsoo (M)

Department of Medical Biotechnology, National Research Institute of Genetic Engineering and Biotechnology, Tehran, Iran.

Mojtaba Ahmadzadeh-Darinsoo (M)

Department of Medical Biotechnology, National Research Institute of Genetic Engineering and Biotechnology, Tehran, Iran.

Shahsanam Abbasi (S)

Department of Agricultural Biotechnology, National Research Institute of Genetic Engineering and Biotechnology, Tehran, Iran.

Ehsan Arefian (E)

School of Biology, College of Science, University of Tehran, Tehran, Iran.

Claude Bernard (C)

Australian Regenerative Medicine Institute, Monash University, Melbourne, 3800, Victoria, Australia.

Azita Parvaneh Tafreshi (AP)

Department of Medical Biotechnology, National Research Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
School of Biology, College of Science, University of Tehran, Tehran, Iran.

Classifications MeSH